Skip to main content
Equibles

Patient Capital Management, LLC

Position in PGEN — Precigen, Inc.

CIK 1854794 BALTIMORE, MD
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$108,510,763
+$39,557,476 QoQ
Shares Held
19,036,976
+6.8% QoQ
Ownership
5.32%
of shares outstanding
% of Portfolio
3.61%
of 13F equity value
Holder Rank
#1
of 210 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 79% Shared 0% None 21%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Derivatives in PGEN

reported options exposure · as of Mar 31, 2022
CallValue
$949,500
CallShares
450,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Patient Capital Management, LLC holds $310,295,927 across 2 Biotechnology names. PGEN ranks #2 (35.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 3,598,808 $201,785,164
2 PGEN
Precigen, Inc.
This page 		19,036,976 $108,510,763

All Filings in PGEN

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $108,510,763 19,036,976
2026-03-31 $68,953,287 17,817,387
2025-12-31 $78,055,087 18,673,466
2025-09-30 $87,056,189 26,460,848
2025-06-30 $23,101,612 16,268,741
2025-03-31 $25,884,728 17,372,301
2024-12-31 $20,026,995 17,881,246
2024-09-30 $17,040,809 17,937,694
2024-06-30 $28,715,959 18,174,658
2024-03-31 $25,307,509 17,453,455
2023-12-31 $21,418,158 15,983,700
2023-09-30 $19,529,509 13,753,176
2023-06-30 $12,930,094 11,243,560
2023-03-31 $1,551,585 1,463,760
2022-12-31 $1,213,264 798,200
2022-09-30 $632,184 298,200
2022-06-30 $399,588 298,200
2022-03-31 $629,202 298,200
2022-03-31 $949,500 450,000
2021-12-31 $1,106,322 298,200